DRG Will Exhibit at Arab Health 2016!

Jul 28, 2016Events

We are pleased to announce that the DRG Group will exhibit at the largest healthcare exhibition & congress in the Middle East: ARAB HEALTH. The show will take place at Dubai International Convention & Exhibition Centre, from January 25 – 28, 2016.

In addition to the presentation of several new assays we will offer live demonstrations of our fully automated random access analyzer: DRG:HYBRiD-XL®.

arab-health-2016

DRG is also proud to highlight our newest ELISAs like DHT-optimized and Hepcidin 25 (bioactive) High Sensitive ELISA kit.

To learn more about DRG’s Hepcidin kit or the DRG:HYBRiD-XL®, please visit our booth in hall Za´abeel 6, Z6A19!

Meet us in the Medlab section!

arab-health-online-2016

[starbox]

News and Updates

BioCheck Inc Acquires DRG International Inc

by Oleg Vishnevski | Aug 18, 2021 | News | 0 Comments

Transformative deal significantly increases IVD development, manufacturing and sales channel for novel ELISA and Chemiluminescent immunoassay platforms.

Parasites & Helicobacter Pylori in Egyptian Children | Calprotectin- DRG:HYBRiD-XL

by Oleg Vishnevski | Apr 8, 2021 | News, Products | 0 Comments

Parasites & Helicobacter Pylori in Egyptian Children with or without Diabetes with Gastrointestinal Manifestations & High Calprotectin Level

Cortisol & Adrenal Androgens as Independent Predictors

by Oleg Vishnevski | Jan 28, 2021 | Products | 0 Comments

Cortisol and adrenal androgens as independent predictors of mortality in septic patients. Abstract Background and Objective To determine the prognostic value of cortisol, Dehydroepiandrosterone (DHEA) and Dehydroepiandrosterone-sulfate (DHEAS), together with their...

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.